The American Diabetes Association Research Foundation presented Adriana Guzmán Monroy, M.D., Ph.D., currently a type 2 diabetes investigator, with the 2005 American Diabetes Association-Takeda Pharmaceuticals Mentor-Based Minority Postdoctoral Fellowship Award, which supports her work. Dr. Monroy was one of three postdoctoral fellows selected to pursue basic or clinical research projects aimed at preventing, treating and curing diabetes.
Through her research, Dr. Monroy intends to identify novel therapeutic approaches to reverse defects in insulin action and correct hyperglycemia (high blood glucose levels). Dr. Monroy is working under the tutelage of established diabetes research investigator Ralph DeFronzo, M.S., M.D., professor and chief of the Health Science Center’s division of diabetes and deputy director of the Texas Diabetes Institute, who will serve as her mentor. Dr. Monroy’s award was presented at the American Diabetes Association’s 65th Annual Scientific Sessions in San Diego June 12. The grant began July 1 and will last for one year.
According to the American Diabetes Association, there are currently more than 18 million people in the United States who live with diabetes. The association said Takeda’s ongoing support will provide Dr. Monroy with an opportunity to intensify her research in type 2 diabetes.
Fellowship candidates submitted applications demonstrating scientific abilities and research potential that meet the strict criteria of the association's peer review process. The American Diabetes Association/Takeda Pharmaceuticals Mentor-Based Minority Postdoctoral Fellowship Awards are supported by a three-year $315,000 commitment from Takeda Pharmaceuticals North America, Inc.
For more information, visit
www.diabetes.org or
www.tpna.com.
